Medcompli
CMS Open Payments and Sunshine Reporting Compliance Software.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
* | N/A | Acquisition | |
| Total Funding | 000k | ||
| USD | 2021 | 2022 | 2023 |
|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 |
| % growth | - | 250 % | 136 % |
| EBITDA | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
MedCompli, founded in 2017 by Christopher Gingras, provides compliance management software solutions tailored for the healthcare, life science, and pharmaceutical sectors. Gingras, a compliance expert with over two decades of experience, established the company to address complex regulatory issues and help organizations develop global compliance programs. His background includes serving as a Lieutenant Commander in the U.S. Navy and holding an M.B.A. from Rice University, experiences that shaped his approach to simplifying day-to-day compliance tasks.
The company operates on a software-as-a-service (SaaS) business model, generating recurring revenue through subscriptions to its cloud-based platform. MedCompli targets a range of clients, from emerging biotech firms to large pharmaceutical and medical device companies. The business was developed by experienced compliance officers to offer intuitive and configurable tools for navigating complex regulations. On May 17, 2024, MedCompli was acquired by MediSpend, a global technology company in the life sciences industry. This acquisition was a strategic move for MediSpend to enhance its product portfolio and expertise, with Gingras joining as Chief Product Strategy Officer.
MedCompli's platform is a comprehensive hub for compliance activities. Its key services include managing Healthcare Professional (HCP) engagements, determining Fair Market Value for compensation, conducting third-party due diligence, and simplifying CMS Open Payments reporting. The software offers features like a request hub to automate planning and payments for consulting engagements and a grant management module to track external funding and donations. The platform is designed to be cost-effective, providing enterprise-grade functionality at a lower price point compared to competitors. It helps clients manage HCP contracts, discover compliance risks, and ensure adherence to state and federal transparency mandates.
Keywords: compliance management, life sciences, pharmaceutical compliance, regulatory software, SaaS, HCP engagement, fair market value, transparency reporting, grant management, third-party due diligence, MedTech, healthcare compliance, Chris Gingras, MediSpend, Open Payments, compliance automation, risk mitigation, regulatory technology, medical device compliance, biotech compliance, ethics management